Lakeshore Biopharma Co, Stock Buy Hold or Sell Recommendation
LSBPW Stock | 0.04 0.01 33.33% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding LakeShore Biopharma Co, is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell LakeShore Biopharma Co, given historical horizon and risk tolerance towards LakeShore Biopharma. When Macroaxis issues a 'buy' or 'sell' recommendation for LakeShore Biopharma Co,, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out LakeShore Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as LakeShore and provide practical buy, sell, or hold advice based on investors' constraints. LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
LakeShore |
Execute LakeShore Biopharma Buy or Sell Advice
The LakeShore recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on LakeShore Biopharma Co,. Macroaxis does not own or have any residual interests in LakeShore Biopharma Co, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute LakeShore Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
LakeShore Biopharma Trading Alerts and Improvement Suggestions
LakeShore Biopharma generated a negative expected return over the last 90 days | |
LakeShore Biopharma has high historical volatility and very poor performance | |
LakeShore Biopharma has some characteristics of a very speculative penny stock | |
LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
LakeShore Biopharma Co, was previously known as YS Biopharma Co, and was traded on NASDAQ Exchange under the symbol YSBPW. | |
The company reported the revenue of 573.42 M. Net Loss for the year was (433.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
LakeShore Biopharma generates negative cash flow from operations | |
LakeShore Biopharma has a frail financial position based on the latest SEC disclosures |
LakeShore Biopharma Returns Distribution Density
The distribution of LakeShore Biopharma's historical returns is an attempt to chart the uncertainty of LakeShore Biopharma's future price movements. The chart of the probability distribution of LakeShore Biopharma daily returns describes the distribution of returns around its average expected value. We use LakeShore Biopharma Co, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of LakeShore Biopharma returns is essential to provide solid investment advice for LakeShore Biopharma.
Mean Return | -0.75 | Value At Risk | -22.42 | Potential Upside | 26.88 | Standard Deviation | 11.52 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of LakeShore Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
LakeShore Biopharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to LakeShore Biopharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that LakeShore Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a LakeShore stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.93 | |
β | Beta against Dow Jones | 1.41 | |
σ | Overall volatility | 11.52 | |
Ir | Information ratio | -0.08 |
LakeShore Biopharma Volatility Alert
LakeShore Biopharma Co, is displaying above-average volatility over the selected time horizon. LakeShore Biopharma Co, is a penny stock. Although LakeShore Biopharma may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in LakeShore Biopharma Co,. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on LakeShore instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.LakeShore Biopharma Fundamentals Vs Peers
Comparing LakeShore Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze LakeShore Biopharma's direct or indirect competition across all of the common fundamentals between LakeShore Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as LakeShore Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of LakeShore Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing LakeShore Biopharma by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare LakeShore Biopharma to competition |
Fundamentals | LakeShore Biopharma | Peer Average |
Revenue | 573.42 M | 9.43 B |
EBITDA | (368.66 M) | 3.9 B |
Net Income | (433.46 M) | 570.98 M |
Total Debt | 424.46 M | 5.32 B |
Cash Flow From Operations | (295.23 M) | 971.22 M |
Number Of Employees | 758 | 18.84 K |
Total Asset | 1.51 B | 29.47 B |
Retained Earnings | (2.31 B) | 9.33 B |
Working Capital | 100.94 M | 1.48 B |
Net Asset | 1.51 B |
LakeShore Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as LakeShore . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About LakeShore Biopharma Buy or Sell Advice
When is the right time to buy or sell LakeShore Biopharma Co,? Buying financial instruments such as LakeShore Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having LakeShore Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Value Funds Thematic Idea Now
Small Value Funds
Funds or Etfs that invest in the undervalued stocks of small to mid-sized companies. The Small Value Funds theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Value Funds Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.